Le

OTC products · Product label record

Leader Eye Drops Redness Relief drug information

GLYCERIN, NAPHAZOLINE HYDROCHLORIDE
Cardinal Health · OPHTHALMIC

Product NDC: 70000-0010

Join the community
CommunityExperiencesReviewsDrug database
Source label information, not individualized medical advice. This record applies to the product and labeler shown below. Compare the exact formulation, strength and country with your package and the current source label.
Generic nameGLYCERIN, NAPHAZOLINE HYDROCHLORIDE
Labeler / manufacturerCardinal Health
RouteOPHTHALMIC
Drug classNon-Standardized Chemical Allergen
Product NDC70000-0010
Label effective date2026-09-09

Official product label reference

Leader Eye Drops Redness Relief — Cardinal Health

This page contains 13 source sections for GLYCERIN, NAPHAZOLINE HYDROCHLORIDE, ophthalmic route. Label set aee4bbe2-4f11-4c54-be8b-df48b3ba4f3a, version 7.

Retrieved 2026-10-02 · openFDA dataset updated 2026-10-02 · Check the current DailyMed label

Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.

Uses described in the label

Uses for the relief of redness of the eye due to minor eye irritations for the temporary relief of burning and irritation due to dryness of the eye for use as a protectant against further irritation or dryness of the eye

Purpose

Purposes Glycerin...Lubricant Naphazoline hydrochloride...Redness reliever
Dosage and administration — label text
Directions Instill 1 or 2 drops in the affected eye(s) up to 4 times daily children under 6 years of age:ask a doctor
Warnings
Warnings For external use only Do not use if solution changes color or becomes cloudy Ask a doctor before use if you have narrow angle glaucoma When using this product to avoid contamination, do not touch tip of container to any surface replace cap after using overuse may produce increased redness of the eye pupils may become enlarged temporarily Stop use and ask a doctor if you experience eye pain you experience changes in vision you experience continued redness or irritation of the eye the condition worsens or persists for more than 72 hours Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Active ingredient
Active ingredients Glycerin 0.25% Naphazoline hydrochloride 0.012%
Do not use
Do not use if solution changes color or becomes cloudy
Ask a doctor before use
Ask a doctor before use if you have narrow angle glaucoma
While using this medicine
When using this product to avoid contamination, do not touch tip of container to any surface replace cap after using overuse may produce increased redness of the eye pupils may become enlarged temporarily
When to stop use and seek help
Stop use and ask a doctor if you experience eye pain you experience changes in vision you experience continued redness or irritation of the eye the condition worsens or persists for more than 72 hours
Child safety
Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Other safety information
Other information store at room temperature remove contact lenses before using
Inactive ingredient
Inactive ingredients benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate
Questions
Questions or comments? Call 1-888-527-4276

Official sources and product identifiers

Substances listed: GLYCERIN, NAPHAZOLINE HYDROCHLORIDE

RxNorm identifiers: 1046700

Package NDC codes

70000-0010-1, 70000-0010-2

Further research and background

These are external searches for related information. Research, encyclopedia and news articles have not been imported into this product record.

Coverage and corrections

The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.

Source retrieved 2026-10-02. Read the source policy.